![Helen Torley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Torley
Chief Executive Officer at
HALOZYME THERAPEUTICS, INC.
Net worth: 51 M $ as of 31/05/2026
Profile
Helen I. Torley occupies the position of President, Chief Executive Officer & Director at Halozyme Therapeutics, Inc. She is also on the board of Quest Diagnostics, Inc. and Director & Member-Health Section Governing Board at Biotechnology Innovation Organization and Member of The Royal College of Physicians. In the past she was Vice President & GM-United States Bone Health at Amgen, Inc. and Chief Commercial Officer & Executive VP for Onyx Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.), Vice President-Medical Affairs of Novartis, Inc., Vice President-Medical Affairs for Sandoz SA and Vice President-Cardiovascular & Metabolic Sales at Bristol-Myers Squibb World Wide Medicines Group. She received an undergraduate degree from the University of Glasgow.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2026 | 767,780 ( 0.65% ) | 51 M $ | 31/05/2026 |
Helen Torley active positions
| Companies | Position | Start |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Executive Officer | 06/01/2014 |
| ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of Helen Torley
| Companies | Position | End |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Director/Board Member | 18/05/2022 |
| RELYPSA INC | Director/Board Member | 01/09/2016 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Chief Operating Officer | 15/12/2011 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2002 |
Training of Helen Torley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Quest Diagnostics, Inc.
 Quest Diagnostics, Inc. Services to the Health IndustryHealth Services Provides diagnostic testing and information services | Health Services |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Sandoz SA |
- Stock Market
- Insiders
- Helen Torley
